Hassan Awada (@awadahassan_) 's Twitter Profile
Hassan Awada

@awadahassan_

Hematologist/Oncologist via @RoswellPark/@UBuffalo & @Clevelandclinic| Tweets are my own

ID: 1150255734728351744

linkhttps://scholar.google.com/citations?hl=en&user=po4BNewAAAAJ&view_op=list_works calendar_today14-07-2019 04:08:32

227 Tweet

611 Followers

710 Following

Roswell Park Hematology/Oncology Fellowship (@roswellhemonc) 's Twitter Profile Photo

We are EXTREMELY proud of our fellows for spending their free time caring for our patients at Roswell Park during the #BlizzardOf22 #BuffaloBlizzard2022 Mark Faber and Hassan Awada managed inpatient Roswell Park Leukemia and Hospitalist patients through our moonlighting program.

Carmelo Gurnari (@carmelogurnari) 's Twitter Profile Photo

Once again a success of the team confirming that spliceopathy is a hallmark of MN beyond the mere SF mutations “A multimodal analysis of genomic and RNA-splicing features in myeloid malignancies” cell.com/iscience/fullt…

Once again a success of the team confirming that spliceopathy is a hallmark of MN beyond the mere SF mutations “A multimodal analysis of genomic and RNA-splicing features in myeloid malignancies” cell.com/iscience/fullt…
Liam Satre Meloy (@lsatremeloy) 's Twitter Profile Photo

My 3 year old daughter Lila was recently diagnosed with a VERY rare and aggressive type of #leukemia. 👉 It’s potentially treatment resistant… AND 👉 Requires a bone marrow transplant. A🧵with all the details we have so far 👇 Please @Twitter help me save my little girl.

My 3 year old daughter Lila was recently diagnosed with a VERY rare and aggressive type of #leukemia.

👉 It’s potentially treatment resistant… AND 

👉 Requires a bone marrow transplant. 

A🧵with all the details we have so far 👇

Please @Twitter help me save my little girl.
Carmelo Gurnari (@carmelogurnari) 's Twitter Profile Photo

HMA (AZA and DEC) are a mainstay in the current management of patients with MDS and AML as either single agents or in multidrug combinations. But what do we do when patients become resistant or are primary refractory? We outline this issue here👇 doi.org/10.3390/cancer…

Carmelo Gurnari (@carmelogurnari) 's Twitter Profile Photo

Molecular patterns identify distinct subclasses of myeloid neoplasia | out in ⁦Nature Communications⁩ our latest effort illuminating MN: ⁦Valeria Visconte⁩ ⁦tariqkewan⁩ ⁦Arda Durmaz⁩ ⁦AA&MDSIF⁩ ⁦MDS Foundation⁩ ⁦MDS Hub⁩ nature.com/articles/s4146…

Carmelo Gurnari (@carmelogurnari) 's Twitter Profile Photo

Finally out and kudos to Dr.Hussein Awada!! Collaboration dream team Cleveland Clinic We studied a cohort of 1507 patients undergoing aHSCT and 263 patients who developed tMN without aHSCT to determine clinico-molecular features unique to post-aHSCT tMN.

Finally out and kudos to Dr.Hussein Awada!! Collaboration dream team <a href="/ClevelandClinic/">Cleveland Clinic</a> We studied a cohort of 1507 patients undergoing aHSCT and 263 patients who developed tMN without aHSCT to determine clinico-molecular features unique to post-aHSCT tMN.
Hematopoiesis News (@hema_news) 's Twitter Profile Photo

Congratulations to Drs. Hussein Awada, Carmelo Gurnari, and team on their recent Leukemia Journal study! 👏 📖 Here's the full study: go.nature.com/3wg0HOO Follow the author's thread for research highlights. ✨

Carmelo Gurnari (@carmelogurnari) 's Twitter Profile Photo

Context-dependent role of trisomy 6 in myelodysplastic neoplasms and acute myeloid leukemia: a multi-omics analysis | fantastic job by ⁦Hussein M. Awada⁩ ⁦Valeria Visconte⁩ and all the MaciejewskiLab team of ⁦Cleveland Clinic⁩ nature.com/articles/s4137…

Moaath Mustafa Ali, MD, MPH | د. معاذ مصطفى علي (@moaathmustafaal) 's Twitter Profile Photo

🚨🚨 In the FIRST of its kind study, we laid down the basis how to use immune therapy to prevent #cancer. 👉 “Can immune therapy prevent pre-clinical cancer from progression? The impact of immune therapy on secondary cancer incidence.” Please check out our abstract in